About the opportunity
The Technical University of Denmark (DTU), Department of Health Technology, offers a fully funded 3-year postdoc position starting in March 2027. The project focuses on investigating the chemical synthesis, formulation, in vivo delivery, and immunoregulatory action of a series of novel in-house produced compounds. Researchers will use and improve these compounds for delivery into mice, testing their ability to modulate inflammation and cancer immunity. The position is situated in the Section for Experimental and Translation Immunology and involves close collaboration with DTU Chemistry and DTU Health Tech, working within a dynamic and international team.
Salary and benefits
- Fully funded 3-year postdoc appointment based on the collective agreement with the Danish Confederation of Professional Associations
- Supplements can be negotiated in accordance with DTU’s salary structure for scientific staff
- Opportunity to work in a leading technical university globally recognized for research, education, and innovation
Who can apply?
- Must hold a PhD degree by March 2027
- Extensive and demonstrable experience (through publications or thesis work) with mouse immunology (experience with inflammation and tumour models prioritized)
- FELASA B certification or equivalent that licenses work with mice in Europe is mandatory
- Extensive and demonstrable experience with synthetic chemistry
- Extensive and demonstrable experience with Western blotting
- Demonstrable experience with drug formulation and multi-parametric flow cytometry
- Experience with isolation and culture of mouse cells from various organs
- Basic skills in biochemistry such as protein identification, IC50 binding assays, and fluorescence techniques (TRF, FRET, HTRF)
Required documents
- A letter motivating the application (cover letter) – max 1 page
- A 1-page summary outlining experience with immunology and required qualifications
- CV – max 1 page excluding publications
- List of publications
- FELASA B or equivalent certificate
- Contacts of two referees (one must be the supervisor of the PhD thesis)
- PhD and MSc diplomas in English
When to apply
- Application deadline is 15 October 2026 (23:59 Danish time)
- Position starts in March 2027
How to apply
- Open the online application link
- Fill out the online application form
- Attach all required materials in English combined into one PDF file
Additional information
- The position is part of the Section for Experimental and Translation Immunology at DTU Health Tech
- Collaborates with Professor Katrine Qvortrup at DTU Chemistry and Associate Professor Andrew Urquhart at DTU Health Tech
- Open-source background checks may be conducted on qualified candidates due to critical technology research rules
Our Take on This Opportunity
This section reflects Open Opportunities’ own analysis of the opportunity from an applicant’s perspective.
You may be a strong fit if…
- PhD holders with extensive experience in mouse immunology, specifically inflammation and tumour models.
- Researchers with a strong background in synthetic chemistry and Western blotting.
- Specialists in drug formulation and multi-parametric flow cytometry.
What should you think carefully about?
- A FELASA B certification (or European equivalent) for working with mice is mandatory.
- The position is on-site in Kgs. Lyngby, Denmark, and requires a relocation to Denmark.
- Open-source background checks may be conducted due to the critical technology research rules.
How could this fit your current goals and plans?
This 3-year fully funded appointment is an ideal way for a PhD holder to bridge the gap between chemical synthesis and in vivo delivery. It provides a chance to work in a leading technical university and investigate immunoregulatory action of novel compounds in inflammation and cancer immunity.
Our take
A highly specialized postdoc for researchers who possess the exact combination of synthetic chemistry and mouse immunology skills.
Ready to apply?
Review the opportunity on the official website before applying.
Official-source verified
